🇰🇷 Fenmetrazina in South Korea

Fenmetrazina (PHENMETRAZINE) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Marketing authorisation holder: BOEHRINGER INGELHEIM
  • Status: likely_approved

Fenmetrazina in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Metabolic approved in South Korea

Frequently asked questions

Is Fenmetrazina approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for Fenmetrazina in South Korea?

BOEHRINGER INGELHEIM holds the South Korean marketing authorisation.